| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20020555 | HPV | ENSG00000180616.9 | protein_coding | SSTR2 | No | No | 6752 | P30874 |
| TVIS20020556 | HPV | ENSG00000180616.9 | protein_coding | SSTR2 | No | No | 6752 | P30874 |
| TVIS44018052 | HTLV-1 | ENSG00000180616.9 | protein_coding | SSTR2 | No | No | 6752 | P30874 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SSTR2 |
|---|---|
| DrugBank ID | DB13985 |
| Drug Name | Lutetium Lu 177 dotatate |
| Target ID | BE0003528 |
| UniProt ID | P30874 |
| Regulation Type | agonist |
| PubMed IDs | 22388631 |
| Citations | Kam BL, Teunissen JJ, Krenning EP, de Herder WW, Khan S, van Vliet EI, Kwekkeboom DJ: Lutetium-labelled peptides for therapy of neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S103-12. doi: 10.1007/s00259-011-2039-y. |
| Groups | Approved; Investigational |
| Direct Classification | |
| SMILES | [177Lu+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O |
| Pathways | |
| PharmGKB | |
| ChEMBL |
